已收盘 12-12 16:00:00 美东时间
-10.710
-7.82%
今日重点评级关注:Ascendiant Capital:维持GRI Bio"买入"评级,目标价从35美元升至36美元;Ascendiant Capital:维持Atossa Therapeutics"买入"评级,目标价从7.75美元升至8美元
12-09 10:32
JP Morgan analyst Mark Strouse downgrades Primoris Services (NYSE:PRIM) from Overweight to Neutral and lowers the price target from $145 to $143.
12-08 20:30
S&P Dow Jones Indices on Friday announced multiple index changes effective Dec. 22. As part of the rebalancing, Pinterest (PINS) will join the S&P MidCap 400 index (SP400), alongside Booz Allen Hamilt...
12-08 18:40
https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20251205-1480992/1480992_december2025rebalance.pdf
12-06 06:27
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从4美元升至9美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从32美元升至38美元
11-25 10:27
Goldman Sachs analyst Adam Bubes initiates coverage on Primoris Services (NYSE:PRIM) with a Sell rating and announces Price Target of $117.
11-24 20:52
Construction Partners (NASDAQ:ROAD) is set to give its latest quarterly earning...
11-19 23:02
花旗上调Bilibili目标价升至27美元; 摩根士丹利上调英伟达目标价升至220美元;Ardent Health、Stubhub遭多家大行下调评级>>
11-17 10:49
Elon Musk bets on solar as the 'biggest source of power' amid skyrocketing AI data center energy demand. Can orbital solar solve the crisis?
11-14 14:25
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从3美元升至9美元;HC Wainwright & Co.:上调CervoMed评级至"买入",目标价从11美元升至25美元
11-06 09:55